Recruiting Gaucher Disease Studies in San Francisco
About Gaucher Disease Clinical Trials in San Francisco
Gaucher disease is an inherited metabolic disorder caused by deficiency of the enzyme glucocerebrosidase, leading to accumulation of fatty substances in organs. It is the most common lysosomal storage disorder. Treatment includes enzyme replacement therapy and substrate reduction therapy.
There are currently 2 gaucher disease clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 12,045 participants. Research is being sponsored by Genzyme, a Sanofi Company, Spur Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Gaucher Disease Clinical Trials in San Francisco — FAQ
Are there gaucher disease clinical trials in San Francisco?
Yes, there are 2 gaucher disease clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Francisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.
Are clinical trials in San Francisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.
What gaucher disease treatments are being tested?
The 2 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for gaucher disease.
Data updated October 13, 2026 from ClinicalTrials.gov